Fact sheet: AXA Framlington Health

Fund information

Fund name
AXA Framlington Health Z Inc
Fund company manager
AXA IM UK
Fund type
UKA
Fund manager(s)
Dani Saurymper
since 01/04/2015
Fund objective
The aim of this Fund is to provide long-term capital growth.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

2.45 %

1 Year rank in sector

87/109

Sector

UT Specialist

Yield

0.34

Fund size

£ 530.8 m

FE Risk score

146

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    70.91%
  • Europe ex UK
    17.7%
  • UK
    8.73%
  • Japan
    2.63%
  • Money Market
    0.03%
  • Biotechnology/Medical
    30.54%
  • Pharmaceuticals
    29.2%
  • Health Care
    20.03%
  • Healthcare & Medical Products
    16.15%
  • Hospital
    1.6%
  • North American Equities
    70.91%
  • Europe ex UK Equities
    17.7%
  • UK Equities
    8.73%
  • Japanese Equities
    2.63%
  • Money Market
    0.03%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund1.57 %3.99 %2.45 %50.62 %117.58 %
Sector1.99 %4.61 %6.91 %28.34 %33.51 %
Rank within sector63 / 11366 / 11387 / 10924 / 1046 / 89
Quartile th3 rd3 rd4 th1 st1 st

Calendar performance

YTD-20172016201520142013
Fund7.26 %7.81 %12.24 %29.57 %34.56 %
Sector7.46 %22.72 %-4.47 %1.15 %4.5 %
Rank within sector63 / 10979 / 1085 / 1045 / 1002 / 90
Quartile th3 rd3 rd1 st1 st1 st

Risk statistics

Alpha6.44
Beta0.79
Sharpe0.58
Volatility14.71
Tracking error12.58
Information ratio0.32
R-Squared0.28

Price movement

52 week high128.6
52 week low107.8
Current bid price0
Current offer price0
Current mid price122.6

Holdings by region

  • 70.91% North America
  • 17.7% Europe ex UK
  • 8.73% UK
  • 2.63% Japan
  • 0.03% Money Market

Holdings by sector

  • 30.54% Biotechnology/Medical
  • 29.2% Pharmaceuticals
  • 20.03% Health Care
  • 16.15% Healthcare & Medical Products
  • 1.6% Hospital
  • 1.46% Conglomerates
  • 0.99% Food & Drug Retailers
  • 0.03% Money Market

Holdings by asset type

  • 70.91% North American Equities
  • 17.7% Europe ex UK Equities
  • 8.73% UK Equities
  • 2.63% Japanese Equities
  • 0.03% Money Market

Individual holdings

  • 5.32% UNITEDHEALTH GROUP INC
  • 5.01% GLAXOSMITHKLINE
  • 4.86% ROCHE HLDG AG
  • 4.63% CELGENE CORP
  • 4.44% GILEAD SCIENCES INC
  • 4.24% ALLERGAN PLC
  • 3.57% MEDTRONIC INC
  • 3.02% THERMO FISHER SCIENTIFIC INC
  • 2.82% LILLY (ELI) & CO
  • 2.54% BIOGEN INC